Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Du

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Comparative Effectiveness Research|February 16, 2026
Real-world clinical outcomes of patients with localized prostate cancer treated with radical prostatectomy in SEER-MedicareLawrence Karsh, Shawn Du, Jinghua He, et al.
Health Affairs (Project Hope)|September 4, 2019
Experiment To Decrease Neighborhood Poverty Had Limited Effects On Emergency Department UseCraig E Pollack, Shawn Du, Amanda L Blackford, et al.
The Prostate|April 30, 2024
Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapyLawrence Karsh, Shawn Du, Jinghua He, et al.
Journal of Health Economics and Outcomes Research|August 1, 2025
Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate CancerShawn Du, Carmine Rossi, Ibrahim Khilfeh, et al.
JAMA Psychiatry|April 16, 2020
Health Care Spending by Enrollees With Substance Use and Mental Health Disorders in High-Deductible Health Plans vs Traditional PlansMatthew D Eisenberg, Shawn Du, Aditi P Sen, et al.
Advances in Therapy|May 29, 2025
Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended TherapyAlexander I Spira, Tao Ran, Iris Lin, et al.
JAMA|December 4, 2019
Association of Receipt of a Housing Voucher With Subsequent Hospital Utilization and SpendingCraig Evan Pollack, Amanda L Blackford, Shawn Du, et al.
Journal of Health Economics and Outcomes Research|September 13, 2024
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology SettingBenjamin H Lowentritt, Carmine Rossi, Erik Muser, et al.
Journal of Health Economics and Outcomes Research|January 2, 2026
Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone AcetateGordon Brown, Sabree Burbage, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|January 16, 2026
Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamideBenjamin H Lowentritt, Sabree Burbage, Ibrahim Khilfeh, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Comparative Effectiveness Research|February 16, 2026
Real-world clinical outcomes of patients with localized prostate cancer treated with radical prostatectomy in SEER-MedicareLawrence Karsh, Shawn Du, Jinghua He, et al.
Health Affairs (Project Hope)|September 4, 2019
Experiment To Decrease Neighborhood Poverty Had Limited Effects On Emergency Department UseCraig E Pollack, Shawn Du, Amanda L Blackford, et al.
The Prostate|April 30, 2024
Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapyLawrence Karsh, Shawn Du, Jinghua He, et al.
Journal of Health Economics and Outcomes Research|August 1, 2025
Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate CancerShawn Du, Carmine Rossi, Ibrahim Khilfeh, et al.
JAMA Psychiatry|April 16, 2020
Health Care Spending by Enrollees With Substance Use and Mental Health Disorders in High-Deductible Health Plans vs Traditional PlansMatthew D Eisenberg, Shawn Du, Aditi P Sen, et al.
Advances in Therapy|May 29, 2025
Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended TherapyAlexander I Spira, Tao Ran, Iris Lin, et al.
JAMA|December 4, 2019
Association of Receipt of a Housing Voucher With Subsequent Hospital Utilization and SpendingCraig Evan Pollack, Amanda L Blackford, Shawn Du, et al.
Journal of Health Economics and Outcomes Research|September 13, 2024
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology SettingBenjamin H Lowentritt, Carmine Rossi, Erik Muser, et al.
Journal of Health Economics and Outcomes Research|January 2, 2026
Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone AcetateGordon Brown, Sabree Burbage, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|January 16, 2026
Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamideBenjamin H Lowentritt, Sabree Burbage, Ibrahim Khilfeh, et al.
Pageof 3